Skip to content
healthcare.dev
Get a free key

TAZAROTENE

NDC 45802-436, tazarotene, gel, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-436
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213079
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-436 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAZAROTENE.5 mg/g

Pharmacologic classes

Retinoid [EPC]; Retinoids [CS]

Package NDCNDC-11Package
45802-436-01458020436011 TUBE in 1 CARTON (45802-436-01) / 100 g in 1 TUBE
45802-436-94458020436941 TUBE in 1 CARTON (45802-436-94) / 30 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ffd11dee-4266-4201-9573-1e82c2d30a63

  • NADAC price for package 45802043694

    GET /v1/drugs/nadac/45802043694

Use it

Look up 45802-436 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-436 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-436. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.